©2022 Stanford Medicine
Single Session Class to Reduce Opioid Use in Chronic Pain
Recruiting
I'm InterestedTrial ID: NCT03950791
Purpose
Prescription opioids are one of the most commonly used treatments for chronic pain, despite
limited evidence of their efficacy and high morbidity and mortality risks. The study aims to
determine the efficacy of a targeted single-session psychology class in reducing opioid use
among patients with chronic pain. The information gained from this study has the potential to
identify patients who achieve a meaningful reduction in opioid use and inform opioid
reduction strategies.
Official Title
Single Session Pain Catastrophizing Class: Efficacy & Mechanisms for Reducing Opioid Use Among Chronic Pain Patients
Stanford Investigator(s)
Maisa Ziadni, PhD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Eligibility
Inclusion Criteria:
- 18-80 years of age
- Diagnosis of chronic non-cancer pain (> 3 months in duration)
- Currently using prescription opioids ≥ 20mg morphine equivalent daily dose (MEDD) for
≥ 3 months;
- Ability and willingness to complete study procedures.
Exclusion Criteria:
- Open litigation regarding a medical condition
- Inability to provide informed consent and complete study procedures
- Active suicidality.
Intervention(s):
behavioral: Pain Catastrophizing Class
behavioral: Health Education
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Maisa Ziadni
313-725-0615